Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Travel Vaccines Market From 2025 to 2029?

In recent times, there has been robust expansion in the travel vaccines market. The market value is projected to rise from $4.73 billion in 2024 to $5.09 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The market’s growth during the historic period is due to factors such as escalating international travel, government endeavors for travel health, disease globalization, heightened awareness among travelers, and the growth of the travel and tourism sector.

In the coming years, the travel vaccines market size is poised for significant expansion, estimated to reach “$7.36 billion in 2029 with a compound annual growth rate (CAGR) of 9.6%. The predicted growth in this period is attributed to a higher incidence of business travel, the emergence of infectious diseases, governmental regulations and entry requirements, the increasing interest in exotic travel destinations, and cooperative activities between governments and pharmaceutical corporations. The forecast period is also marked by unique industry trends such as personalized vaccination strategies, market growth in non-endemic areas, the embrace of digital healthcare technologies, regulatory backing, expedited approvals, and innovative advancements.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

What Elements Are Contributing To Growth In The Travel Vaccines Market?

The surge in travel and tourism is predicted to stimulate the travel vaccine market’s growth in the foreseeable future. Travel and tourism involve the transfer of people or objects, utilizing various modes of transport such as trains, boats, airplanes, and other vehicles across different far-flung geographic locations. Travel vaccines serve an integral role in protecting tourists and travelers, ensuring their health and safety during their international travels. To exemplify, the United Nations World Tourism Organization (UNWTO), an intergovernmental organization headquartered in Spain and dedicated to promoting tourism, reported in January 2023 that the number of tourists traveling abroad in 2022 exceeded 900 million. This figure is twice the number in 2021 and a 63% increase from before the pandemic. As a result, the escalating travel and tourism trend fuels the expansion of the travel vaccine market.

The travel vaccines market covered in this report is segmented –

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,

2) By Composition: Mono Vaccines, Combination Vaccines

3) By Booking Channel: Online Booking, In-Person Booking

4) By Application: Domestic Travel, Outbound Travel

Subsegments:

1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines

2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)

3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines

4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine

5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines

6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine

7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)

8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine

9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

What Future Market Trends Are Projected For The Travel Vaccines Industry?

The trend of product innovation is becoming increasingly prominent in the travel vaccine market. Major players in this market are creating groundbreaking vaccines to maintain their standing. For example, in August 2022, Indonesian National Agency for Drug and Food Control approved QDENGA (Dengue Tetravalent Vaccine) (TAK-003) developed by Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical firm, to prevent dengue disease caused by any serotype in individuals between six and 45 years old. QDENGA demonstrated its ongoing effectiveness in preventing dengue disease and subsequent hospitalization three years post-immunization, irrespective of a person’s previous exposure to the illness.

Who Are The Key Contributors To Growth In The Travel Vaccines Market?

Major companies operating in the travel vaccines market include Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.

https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

Which Region Is Projected To Lead The Travel Vaccines Market By 2025?

North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11918&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model